Exploring Aztreonam in Combination with Ceftazidime-Avibactam or Meropenem-Vaborbactam as Potential Treatments for Metallo- and Serine-β-Lactamase-Producing Enterobacteriaceae
- 1 December 2019
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 63 (12)
Abstract
Metallo-β-lactamase (MBL)-producing Enterobacteriaceae , particularly those that coharbor serine β-lactamases, are a serious emerging public health threat given their rapid dissemination and the limited number of treatment options. Preclinical and anecdotal clinical data support the use of aztreonam in combination with ceftazidime-avibactam against these pathogens, but other aztreonam-based combinations have not been explored.Keywords
This publication has 23 references indexed in Scilit:
- In Vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam against OXA-48-Carrying Enterobacteriaceae Isolated as Part of the International Network for Optimal Resistance Monitoring (INFORM) Global Surveillance Program from 2012 to 2015Antimicrobial Agents and Chemotherapy, 2018
- Clinical outcomes after combination treatment with ceftazidime/avibactam and aztreonam for NDM-1/OXA-48/CTX-M-15-producing Klebsiella pneumoniae infectionJournal of Antimicrobial Chemotherapy, 2017
- Synergistic activity of ceftazidime-avibactam and aztreonam against serine and metallo-β-lactamase-producing gram-negative pathogensDiagnostic Microbiology and Infectious Disease, 2017
- In Vitro Discordance with In Vivo Activity: Humanized Exposures of Ceftazidime-Avibactam, Aztreonam, and Tigecycline Alone and in Combination against New Delhi Metallo-β-Lactamase-Producing Klebsiella pneumoniae in a Murine Lung Infection ModelAntimicrobial Agents and Chemotherapy, 2017
- In vitropharmacokinetics/pharmacodynamics of the combination of avibactam and aztreonam against MDR organismsJournal of Antimicrobial Chemotherapy, 2016
- Randomized pharmacokinetic and drug–drug interaction studies of ceftazidime, avibactam, and metronidazole in healthy subjectsPharmacology Research & Perspectives, 2015
- The β‐Lactams Strike Back: Ceftazidime‐AvibactamPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2015
- The Future of Antibiotics and ResistanceNew England Journal of Medicine, 2013
- Carbapenems: Past, Present, and FutureAntimicrobial Agents and Chemotherapy, 2011
- Discovery research: the scientific challenge of finding new antibioticsJournal of Antimicrobial Chemotherapy, 2011